Literature DB >> 18650069

The association between schizophrenia and smoking: unexplained by either the illness or the prodromal period.

Francisco J Diaz1, Diana M Velásquez, Margaret T Susce, Jose de Leon.   

Abstract

Age at onset of daily smoking (AODS) was compared in schizophrenia (N=258), mood disorders (N=166) and controls (N=381) to replicate a different AODS in schizophrenia patients, and to confirm that this is not necessarily explained by the prodromal period. The cumulative hazard curves for schizophrenia, mood disorders and controls were significantly different (p<0.001), even after controlling for gender and education (p<0.001). After excluding the patients who started smoking within 5 years of starting psychiatric medication, the cumulative hazard curve for schizophrenia patients was significantly different from that for ever-smoker controls (p=0.002), even after adjusting for gender and education (p=0.03).

Entities:  

Mesh:

Year:  2008        PMID: 18650069     DOI: 10.1016/j.schres.2008.06.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  13 in total

1.  Smoking and schizophrenia in population cohorts of Swedish women and men: a prospective co-relative control study.

Authors:  Kenneth S Kendler; Sara Larsson Lönn; Jan Sundquist; Kristina Sundquist
Journal:  Am J Psychiatry       Date:  2015-06-05       Impact factor: 18.112

Review 2.  Smoking in schizophrenic patients: A critique of the self-medication hypothesis.

Authors:  Francesca Manzella; Susan E Maloney; George T Taylor
Journal:  World J Psychiatry       Date:  2015-03-22

Review 3.  Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders.

Authors:  Smita Das; Judith J Prochaska
Journal:  Expert Rev Respir Med       Date:  2017-08-09       Impact factor: 3.772

4.  Insular and anterior cingulate circuits in smokers with schizophrenia.

Authors:  Lauren V Moran; Hemalatha Sampath; Elliot A Stein; L Elliot Hong
Journal:  Schizophr Res       Date:  2012-09-27       Impact factor: 4.939

5.  A CHRNA5 allele related to nicotine addiction and schizophrenia.

Authors:  L E Hong; X Yang; I Wonodi; C A Hodgkinson; D Goldman; O C Stine; E S Stein; G K Thaker
Journal:  Genes Brain Behav       Date:  2011-04-06       Impact factor: 3.449

Review 6.  Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings.

Authors:  Jose de Leon; Francisco J Diaz
Journal:  Hum Genet       Date:  2011-12-22       Impact factor: 4.132

7.  Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden.

Authors:  Jianguang Ji; Kristina Sundquist; Yi Ning; Kenneth S Kendler; Jan Sundquist; Xiangning Chen
Journal:  Schizophr Bull       Date:  2012-04-20       Impact factor: 9.306

8.  Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population.

Authors:  Xiang Yang Zhang; Da Chun Chen; Yun Long Tan; Mei Hong Xiu; Jingyi Cui; Li Hui; Fu De Yang; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2013-08-21       Impact factor: 4.530

Review 9.  New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.

Authors:  J Alex Grizzell; Valentina Echeverria
Journal:  Neurochem Res       Date:  2014-06-27       Impact factor: 3.996

Review 10.  Update on Smoking Cessation: E-Cigarettes, Emerging Tobacco Products Trends, and New Technology-Based Interventions.

Authors:  Smita Das; Makenzie Tonelli; Douglas Ziedonis
Journal:  Curr Psychiatry Rep       Date:  2016-05       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.